Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.48 |
| ▸ | ACHE | P22303 | 2/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.36 |
| ▸ | LMNA | P02545 | 3/20 | 0.36 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 3/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.34 |
| ▸ | RECQL | P46063 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | PTPRC | P08575 | 1/20 | 0.33 |
| ▸ | S100A4 | P26447 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| 4-Nitrotoluene SCHEMBL13138667 | 0.74 | HSD17B10 (0.70) | TSHRACHEHSD17B10ALDH1A1LMNA | |
| P-Xylene SCHEMBL2137209 | 0.74 | — | — | |
| SCHEMBL17770360 | 0.71 | ALDH1A1 (0.45) | TSHRACHEHSD17B10ALDH1A1LMNA | |
| SCHEMBL13915479 | 0.71 | HSPB1 (0.42) | TSHRACHEHSD17B10ALDH1A1LMNA | |
| P-Nitrophenol SCHEMBL12741899 | 0.71 | ALDH1A1 (0.45) | TSHRHSD17B10ALDH1A1LMNACYP19A1 | |
| SCHEMBL15180914 | 0.71 | MAPK1 (0.46) | TSHRALDH1A1LMNAMAPTHTT | |
| Nitrobenzene SCHEMBL1332838 | 0.70 | — | — | |
| SCHEMBL16530060 | 0.70 | TSHR (0.77) | TSHRACHEALDH1A1LMNAMAPT | |
| SCHEMBL11892517 | 0.68 | TSHR (0.68) | TSHRACHEHSD17B10ALDH1A1LMNA | |
| 4-Nitrobenzoic Acid SCHEMBL10118221 | 0.67 | TDP1 (0.57) | TSHRALDH1A1LMNATDP1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110301113-A1 | PYRIDINEAMINE DERIVATIVES | CONCERT PHARMACEUTICALS INC. | 2011-12-08 | — | — | US | disclosed |
| WO-2010036796-A1 | PYRIDINEAMINE DERIVATIVES | CONCERT PHARMACEUTICALS, INC. (US) | 2010-04-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110301113-A1 | PYRIDINEAMINE DERIVATIVES | FLT1, FLT4, TEK | TSHR 2506/4885ACHE 4849/4885HSD17B10 3880/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.